Most companies win on one count. Smith and Nephew rents out surgical tools and equipment, and our model checks seven angles at once, this one led nearly every angle together.
Fair value according to the model12.7% above the priceThe model puts fair value 12.7% above today's price. It weighs earnings, growth and risk.
How it ran against the rest21.8%Over the past period this stock did better than 22% of the roughly 5,700 stocks we track. High here means it rose more than the rest.
Do you get paid to hold it2.7% a yearThis company pays out roughly 2.7 percent of the share price each year. That part of your return does not have to come from a rising price.
Are profits growing too+52% profitProfit changed by 52 percent against 6 percent of revenue. Profit is growing faster than revenue, which is exactly what you want to see: the company gets more efficient as it grows.
What you pay per dollar of revenue1.5 times annual revenueFor every dollar the company sells, you pay 1.47 dollars in market value. Comparable companies in healthcare cost 3.4 times revenue, so this is cheaper than its neighbours.
You notice when people who work there start buying their own stock while the price sits flat. Morgan Sindall ships construction projects across the UK. Earnings guesses were cut, yet insiders bought in anyway.
Fair value according to the model61.5% above the priceThe model puts fair value 61.5% above today's price. It weighs earnings, growth and risk.
How it ran against the rest37.6%Over the past period this stock did better than 38% of the roughly 5,700 stocks we track. High here means it rose more than the rest.
Do you get paid to hold it4.1% a yearThis company pays out roughly 4.1 percent of the share price each year. That part of your return does not have to come from a rising price.
How far below the year's high28% below the highThe highest price of the past year was 5528.02 dollars; today it trades 28 percent lower. A gap like that can be an opportunity, but it can also be there because something genuinely changed at the company.
Are profits growing too+33% profitProfit changed by 33 percent against 10 percent of revenue. Profit is growing faster than revenue, which is exactly what you want to see: the company gets more efficient as it grows.
Not everyone saw this. Otsuka stamps out medicines millions take daily. The model number is a third higher than the tape, and this rank sits in the front of the tape.
Fair value according to the model39.6% above the priceThe model puts fair value 39.6% above today's price. It weighs earnings, growth and risk.
How it ran against the rest83.9%Over the past period this stock did better than 84% of the roughly 5,700 stocks we track. High here means it rose more than the rest.
Is revenue still growing+6.0% in a yearRevenue grew 6.0 percent over the past year. That is the foundation under everything above.
Does the business earn money21% of revenueOf every 100 dollars of revenue, 21 is left as operating profit, before interest and tax.
Can the company take a hitstrong balance sheetA widely used bankruptcy test scores this company 5.4. Above 3 counts as solid, below 1.8 as fragile. This balance sheet can absorb a bad year.
These are five out of 6,000+
The model runs through every stock each night. Pro shows you the full forecast on any stock, not just the five you see here.
Ninety-six of a hundred. That's where Organon reranked on our board. They smelt generic medicines for millions daily. Today's print trails the model by a third. One red flag though, technical strength sits flat.
Fair value according to the model10.9% above the priceThe model puts fair value 10.9% above today's price. It weighs earnings, growth and risk.
Earnings estimatesstrong upanalysts are raising their earnings estimates sharply
How it ran against the rest96.1%Over the past period this stock did better than 96% of the roughly 5,700 stocks we track. High here means it rose more than the rest.
Company value on the exchange$3.6 bnAll shares together are worth about $3.6 billion. That makes it a smaller player, less known to the wider public.
Can the company take a hitfragile balance sheetA widely used bankruptcy test scores this company 1.0. Above 3 counts as solid, below 1.8 as fragile. This is the zone where companies get into trouble when things go wrong. A low price can be a warning here rather than a discount.
Are profits growing too-78% profitProfit changed by -78 percent against -3 percent of revenue. Revenue and profit are both falling, profit hardest. When revenue shrinks, fixed costs do not shrink along, and that hits profit twice.
What you pay per dollar of revenue0.6 times annual revenueFor every dollar the company sells, you pay 0.60 dollars in market value. Comparable companies in healthcare cost 3.4 times revenue, so this is cheaper than its neighbours.
Eighty-five and a half, that's where Bank of China's climb printed, ahead of almost the whole list we cover. They cuts fees across lending, and estimates led the price this time.
Fair value according to the model91.7% above the priceThe model puts fair value 91.7% above today's price. It weighs earnings, growth and risk.
Earnings estimatesupanalysts are raising their earnings estimates
How it ran against the rest85.5%Over the past period this stock did better than 86% of the roughly 5,700 stocks we track. High here means it rose more than the rest.
Company value on the exchange$252.3 bnAll shares together are worth about $252.3 billion. That makes it one of the largest listed companies in the world.
Can the company take a hitfragile balance sheetA widely used bankruptcy test scores this company 0.1. Above 3 counts as solid, below 1.8 as fragile. This is the zone where companies get into trouble when things go wrong. A low price can be a warning here rather than a discount.
Do you get paid to hold it4.2% a yearThis company pays out roughly 4.2 percent of the share price each year. That part of your return does not have to come from a rising price.
Does the business earn money58% of revenueOf every 100 dollars of revenue, 58 is left as operating profit, before interest and tax. That is well above what is normal in financial companies.
Five more tomorrow
The model runs again every night. If you would rather not wait for tomorrow's selection, look up a stock yourself and see the full forecast.
Published on 1 November 2026. The presenters in these videos are AI-generated. This is not investment advice and not a recommendation; always do your own research.